EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 21 November 2024

Blogs

European Antibiotic Awareness Day: Urgent Need for Sustainable Antimicrobial R&D to Combat...
20 November 2024 - Nathalie Moll

In Europe alone, antimicrobial resistance or AMR results in 35,000 deaths annually, with healthcare costs and productivity... Read more

Advancing the precision oncology agenda in the EU

Watch the event recording to explore successful EU initiatives and regional approaches driving the adoption of precision oncology.

Breaking barriers in Rare Disease Research: The Rare Disease Moonshot at two years

To mark its second anniversary, representatives from patient organizations (EURORDIS), researchers (ERDERA), industry stakeholders (EFPIA), and MEP Voiculescu participated in a Euronews debate to discuss progress, challenges, and necessary systemic changes.

In the two years since its creation, the Rare Disease Moonshot has delivered a shared roadmap for public-private collaborations in the rare disease space. Through collective or individual actions, it has triggered or strengthened public-private collaborations in IHI, European Joint Programme Cofund on Rare Disease (EJP RD) and ERDERA — spanning clinical trials, regulatory science, translational research, and capacity building.

Read more here and watch the highlight video here.

EFPIA Conference – Discover the programme

Join leaders from the pharmaceutical industry, policymakers, patient advocates, and healthcare experts to discuss how we can work together to build a healthier, more competitive Europe.

Discover the programme and register here.

What we are reading

The time is now: Combatting Antimicrobial Resistance with Transferable Exclusivity Vouchers...
On 20 November 2024 (The Parliament Magazine)

The EU has a once-in-a-generation window of opportunity to implement an effective pull incentive for combating AMR.

Health at a Glance: Europe 2024
On 20 November 2024 (European Commission)

The 2024 edition of Health at a Glance: Europe examines key health challenges... Read more

The Economic Impact of the Global Pharmaceutical Industry
On 17 November 2024 (WifOR Institute)

This report was commissioned by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).... Read more

Fostering the international interoperability of clinical research networks to tackle undiagnosed...
On 13 November 2024 (Frontiers)

Clinical research is an essential component to advance diagnosis and therapeutic development. In 2022, the International... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu